178 related articles for article (PubMed ID: 25479078)
1. Discordance rate of HER2 status in primary gastric carcinomas and synchronous lymph node metastases: a multicenter retrospective analysis.
Ieni A; Barresi V; Caltabiano R; Caleo A; Bonetti LR; Lanzafame S; Zeppa P; Caruso RA; Tuccari G
Int J Mol Sci; 2014 Dec; 15(12):22331-41. PubMed ID: 25479078
[TBL] [Abstract][Full Text] [Related]
2. Discordance rate of HER2 status in primary breast carcinomas versus synchronous axillary lymph node metastases: a multicenter retrospective investigation.
Ieni A; Barresi V; Caltabiano R; Cascone AM; Del Sordo R; Cabibi D; Zeppa P; Lanzafame S; Sidoni A; Franco V; Tuccari G
Onco Targets Ther; 2014; 7():1267-72. PubMed ID: 25050068
[TBL] [Abstract][Full Text] [Related]
3. Is her-2 status in the primary tumor correlated with matched lymph node metastases in patients with gastric cancer undergoing curative gastrectomy?
Selcukbiricik F; Erdamar S; Buyukunal E; Serrdengecti S; Demirelli F
Asian Pac J Cancer Prev; 2014; 15(24):10607-11. PubMed ID: 25605147
[TBL] [Abstract][Full Text] [Related]
4. HER2 Status in Premalignant, Early, and Advanced Neoplastic Lesions of the Stomach.
Ieni A; Barresi V; Rigoli L; Caruso RA; Tuccari G
Dis Markers; 2015; 2015():234851. PubMed ID: 26494937
[TBL] [Abstract][Full Text] [Related]
5. Concordance of HER2 status in primary tumour and lymph node metastases in patients with esophageal carcinoma.
König AM; Reeh M; Dancau AM; Rathjens M; Gros S; Uzunoglu FG; Bockhorn M; Simon R; Sauter G; Marx A; Izbicki JR
Anticancer Res; 2013 Nov; 33(11):4975-82. PubMed ID: 24222138
[TBL] [Abstract][Full Text] [Related]
6. Human epidermal growth factor receptor-2 gene amplification in gastric cancer using tissue microarray technology.
Tsapralis D; Panayiotides I; Peros G; Liakakos T; Karamitopoulou E
World J Gastroenterol; 2012 Jan; 18(2):150-5. PubMed ID: 22253521
[TBL] [Abstract][Full Text] [Related]
7. Discordance Rate in Estrogen Receptor, Progesterone Receptor, HER2 Status, and Ki67 Index Between Primary Unifocal and Multiple Homogenous Breast Carcinomas and Synchronous Axillary Lymph Node Metastases Have an Impact on Therapeutic Decision.
Georgescu R; Boros M; Moncea D; Bauer O; Coros MF; Oprea A; Moldovan C; Podoleanu C; Stolnicu S
Appl Immunohistochem Mol Morphol; 2018 Sep; 26(8):533-538. PubMed ID: 28099174
[TBL] [Abstract][Full Text] [Related]
8. HER2 expression variability between primary gastric cancers and corresponding lymph node metastases.
Qiu Z; Sun W; Zhou C; Zhang J
Hepatogastroenterology; 2015; 62(137):231-3. PubMed ID: 25911901
[TBL] [Abstract][Full Text] [Related]
9. Discordances in HER2 status between primary gastric cancer and corresponding metastatic sites.
Gumusay O; Benekli M; Ekinci O; Baykara M; Ozet A; Coskun U; Demirci U; Uner A; Dursun A; Atak EY; Buyukberber S
Jpn J Clin Oncol; 2015 May; 45(5):416-21. PubMed ID: 25732909
[TBL] [Abstract][Full Text] [Related]
10. Her2 amplification is significantly more frequent in lymph node metastases from urothelial bladder cancer than in the primary tumours.
Fleischmann A; Rotzer D; Seiler R; Studer UE; Thalmann GN
Eur Urol; 2011 Aug; 60(2):350-7. PubMed ID: 21640482
[TBL] [Abstract][Full Text] [Related]
11. Benefits of using the cell block method to determine the discordance of the HR/HER2 expression in patients with metastatic breast cancer.
Nakayama Y; Nakagomi H; Omori M; Inoue M; Takahashi K; Maruyama M; Takano A; Furuya K; Amemiya K; Ishii E; Oyama T
Breast Cancer; 2016 Jul; 23(4):633-9. PubMed ID: 25968348
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of HER2 gene status between primary breast cancer and synchronous axillary lymph node metastasis].
Liu YY; Wu SF; Liang ZY; Zeng X
Zhonghua Bing Li Xue Za Zhi; 2016 Jun; 45(6):393-6. PubMed ID: 27256047
[TBL] [Abstract][Full Text] [Related]
13. Alterations in hormonal receptor expression and HER2 status between primary breast tumors and paired nodal metastases: discordance rates and prognosis.
Ba JL; Liu CG; Jin F
Asian Pac J Cancer Prev; 2014; 15(21):9233-9. PubMed ID: 25422206
[TBL] [Abstract][Full Text] [Related]
14. Droplet digital polymerase chain reaction detection of HER2 amplification in formalin fixed paraffin embedded breast and gastric carcinoma samples.
Zhu Y; Lu D; Lira ME; Xu Q; Du Y; Xiong J; Mao M; Chung HC; Zheng G
Exp Mol Pathol; 2016 Apr; 100(2):287-93. PubMed ID: 26626802
[TBL] [Abstract][Full Text] [Related]
15. Concordance Between FISH Analysis of Her-2/Neu Gene in Breast Duct Carcinoma and Corresponding Axillary Nodal Metastases: Egyptian National Cancer Institute Experience.
Badawy OM; Hassan H; ELBakey HA; Mosaad M
Appl Immunohistochem Mol Morphol; 2019 Apr; 27(4):295-300. PubMed ID: 29750667
[TBL] [Abstract][Full Text] [Related]
16. Hormone Receptor Status and HER2 Expression in Primary Breast Cancer Compared With Synchronous Axillary Metastases or Recurrent Metastatic Disease.
Rossi S; Basso M; Strippoli A; Dadduzio V; Cerchiaro E; Barile R; D'Argento E; Cassano A; Schinzari G; Barone C
Clin Breast Cancer; 2015 Oct; 15(5):307-12. PubMed ID: 25922284
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological factors associated with HER2 status in gastric cancer: results from a prospective multicenter observational cohort study in a Japanese population (JFMC44-1101).
Matsusaka S; Nashimoto A; Nishikawa K; Miki A; Miwa H; Yamaguchi K; Yoshikawa T; Ochiai A; Morita S; Sano T; Kodera Y; Kakeji Y; Sakamoto J; Saji S; Yoshida K
Gastric Cancer; 2016 Jul; 19(3):839-51. PubMed ID: 26265390
[TBL] [Abstract][Full Text] [Related]
18. Internodal HER2 heterogeneity of axillary lymph node metastases in breast cancer patients.
Baroš IV; Tanasković N; Pellas U; Eri Ž; Tadić Latinović L; Tot T
Bosn J Basic Med Sci; 2019 Aug; 19(3):242-248. PubMed ID: 30957723
[TBL] [Abstract][Full Text] [Related]
19. HER2 expression in primary gastric cancers and paired synchronous lymph node and liver metastases. A possible road to target HER2 with radionuclides.
Wei Q; Xu J; Shen L; Fu X; Zhang B; Zhou X; Carlsson J
Tumour Biol; 2014 Jul; 35(7):6319-26. PubMed ID: 24643685
[TBL] [Abstract][Full Text] [Related]
20. Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years' follow-up.
Falck AK; Bendahl PO; Chebil G; Olsson H; Fernö M; Rydén L
Breast Cancer Res Treat; 2013 Jul; 140(1):93-104. PubMed ID: 23807420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
